155 related articles for article (PubMed ID: 32446910)
1. Cardiac fibroblast diversity in health and disease.
Soliman H; Rossi FMV
Matrix Biol; 2020 Sep; 91-92():75-91. PubMed ID: 32446910
[TBL] [Abstract][Full Text] [Related]
2. Regulators of cardiac fibroblast cell state.
Bretherton R; Bugg D; Olszewski E; Davis J
Matrix Biol; 2020 Sep; 91-92():117-135. PubMed ID: 32416242
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Fibrosis and Fibroblasts.
Kurose H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359886
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast and Myofibroblast Subtypes: Single Cell Sequencing.
Soliman H; Tung LW; Rossi FMV
Methods Mol Biol; 2021; 2299():49-84. PubMed ID: 34028734
[TBL] [Abstract][Full Text] [Related]
5. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
6. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
7. Myocardial fibroblast-matrix interactions and potential therapeutic targets.
Goldsmith EC; Bradshaw AD; Zile MR; Spinale FG
J Mol Cell Cardiol; 2014 May; 70():92-9. PubMed ID: 24472826
[TBL] [Abstract][Full Text] [Related]
8. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.
Russo I; Frangogiannis NG
J Mol Cell Cardiol; 2016 Jan; 90():84-93. PubMed ID: 26705059
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts.
Avery D; Govindaraju P; Jacob M; Todd L; Monslow J; Puré E
Matrix Biol; 2018 Apr; 67():90-106. PubMed ID: 29248556
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation and cardiac fibrosis: A review on the potential of extracellular matrix proteins as biomarkers.
Reese-Petersen AL; Olesen MS; Karsdal MA; Svendsen JH; Genovese F
Matrix Biol; 2020 Sep; 91-92():188-203. PubMed ID: 32205152
[TBL] [Abstract][Full Text] [Related]
12. Fibroblasts: The arbiters of extracellular matrix remodeling.
DeLeon-Pennell KY; Barker TH; Lindsey ML
Matrix Biol; 2020 Sep; 91-92():1-7. PubMed ID: 32504772
[TBL] [Abstract][Full Text] [Related]
13. Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.
Baci D; Bosi A; Parisi L; Buono G; Mortara L; Ambrosio G; Bruno A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998408
[TBL] [Abstract][Full Text] [Related]
14. Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis.
Phelps M; Stuelsatz P; Yablonka-Reuveni Z
FEBS J; 2016 May; 283(9):1653-68. PubMed ID: 26881702
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
Liguori TTA; Liguori GR; Moreira LFP; Harmsen MC
Sci Rep; 2018 Nov; 8(1):16633. PubMed ID: 30413733
[TBL] [Abstract][Full Text] [Related]
16. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination.
Muhl L; Genové G; Leptidis S; Liu J; He L; Mocci G; Sun Y; Gustafsson S; Buyandelger B; Chivukula IV; Segerstolpe Å; Raschperger E; Hansson EM; Björkegren JLM; Peng XR; Vanlandewijck M; Lendahl U; Betsholtz C
Nat Commun; 2020 Aug; 11(1):3953. PubMed ID: 32769974
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
[TBL] [Abstract][Full Text] [Related]
18. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
19. Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.
Andreae EA; Warejcka DJ; Twining SS
Mol Vis; 2020; 26():540-562. PubMed ID: 32818017
[TBL] [Abstract][Full Text] [Related]
20. Differential β3 Integrin Expression Regulates the Response of Human Lung and Cardiac Fibroblasts to Extracellular Matrix and Its Components.
Merna N; Fung KM; Wang JJ; King CR; Hansen KC; Christman KL; George SC
Tissue Eng Part A; 2015 Aug; 21(15-16):2195-205. PubMed ID: 25926101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
